Sutekast Sunitinib capsules

Get a Price/Quote

MOQ : 1 Bottle

Sutekast Sunitinib capsules Specification

Indication
Treatment of certain types of cancer such as renal cell carcinoma and GIST

Salt Composition
Sunitinib Malate

Dosage Form
Oral solid dose, Capsule

Origin of Medicine
Allopathic

Pacakaging (Quantity Per Box)
28 capsules per box

Drug Type
Prescription medicine

Ingredients
Sunitinib

Physical Form
Capsules

Function
Anti-cancer, kinase inhibitor

Recommended For
Advanced renal cell carcinoma, Gastrointestinal stromal tumors (GIST)

Dosage
50 mg

Dosage Guidelines
As directed by the oncologist or physician

Suitable For
Adults

Quantity
28 capsules Boxes

Storage Instructions
Store below 30C, protect from moisture and light

Sutekast Sunitinib capsules Trade Information

Minimum Order Quantity
1 Bottle

Packaging Details
pack of 28 capsules

Main Domestic Market
All India

Certifications
Brand Name : Sutekast Content : Sunitinib Form : capsules Strength : 50 Mg Packing : Pack Of 28 capsules Manufactured By-: Aprazer

About Sutekast Sunitinib capsules

Specification :-

Brand Name : Sutekast

Content : Sunitinib

Form : capsules

Strength : 50 Mg

Packing : Pack Of 28 capsules

Manufactured By-: Aprazer

Note :- Sutekast Is A Prescription Drug And Should Be Used Under

Proper Medical Guidance And Advice. Do Not Share The Medicine

With Others, Since They May Be Suffering From A Problem That Is

Not Effectively Treated By This Drug.

Advanced Cancer Treatment

Sutekast Sunitinib capsules are specially designed to treat specific advanced cancers like renal cell carcinoma and GIST. As a targeted therapy, they inhibit cancer cell growth and survival, contributing to improved patient outcomes over conventional treatments. Instruction from an oncologist ensures safe and effective therapy.

Precision Dosage and Administration

Each capsule contains 50 mg of Sunitinib Malate, ensuring consistent and reliable dosing for adult patients. The oral administration format makes it convenient for regular intake, with 28 capsules per box supporting a tailored treatment regimen as prescribed by your physician.

FAQs of Sutekast Sunitinib capsules:

Q: How should Sutekast Sunitinib capsules be taken for optimal effectiveness?

A: Sutekast capsules must be taken orally exactly as prescribed by your oncologist or physician. Dosage and treatment duration are determined based on individual medical conditions, so do not alter or skip doses without consulting your healthcare provider.

Q: What are the primary indications for using Sutekast Sunitinib?

A: Sutekast is recommended for adults diagnosed with advanced renal cell carcinoma and gastrointestinal stromal tumors (GIST), offering targeted cancer therapy through its kinase inhibitory action.

Q: When is it appropriate to initiate Sutekast therapy?

A: Sutekast should only be initiated following a thorough evaluation by an oncologist or qualified physician, who will determine suitability based on your specific diagnosis and overall health status.

Q: Where should Sutekast capsules be stored to maintain their efficacy?

A: Store Sutekast capsules below 30C in a dry environment, away from moisture and light, to ensure the medication remains stable and effective throughout its shelf life.

Q: What is the process for obtaining Sutekast capsules?

A: Sutekast is a prescription medicine; it can only be purchased at retail outlets on presentation of a prescription from an oncologist or physician. The medicine is distributed and marketed by Aprazer Healthcare Pvt. Ltd.

Q: Who should avoid taking Sutekast Sunitinib capsules?

A: Sutekast capsules are suitable only for adults and must not be taken by individuals without consultation and approval from a medical specialist experienced in cancer treatment.

Q: What benefits does Sutekast Sunitinib offer during cancer treatment?

A: By specifically targeting cancer cell growth and survival mechanisms, Sutekast can help slow tumor progression and improve treatment responses in eligible patients, leading to better-managed outcomes for advanced renal cell carcinoma and GIST.

Tell us about your requirement